New Study On “2019-2023 Bio-simulation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
Global Bio-simulation Market is predicted to grow significantly with a CAGR 15.5% during 2018-2023 due to rise in adoption of drug discovery and development and success in precision dosing. There are other pivotal factors that are driving the market which includes rising inclination towards personalized medicine, biomedicine and other research projects. Bio-simulation applications such as preclinical testing, clinical trials, target identification and validation, lead identification and optimization are widely adopted. These applications enable to provide faster and more certain results compared to conventional techniques as a result it is widely adopted across the globe. The technological advancement and innovation in Bio-simulation products and applications enable to reduce the number of clinical studies for drug development.
Model-based drug development reduces the clinical studies and offer better results. Bio-simulation have huge contribution in personalized medicines which are adopted widely for better patient care. Due to the advancement in bio-simulation the traditional one size fits all concept is replaced by personalized medicines. Bio-simulation models enable to find better protection against various diseases such as tumour and other cancer cases through precise dozing. As a result, it saves time, effort and money for drug development for many diseases. Bio-simulation technology offers virtual clinical trial population for paediatric, elderly and other group of patients. It enables to perform better clinical trials and reduce the time and effort for drug discovery and development.
Global Bio-simulation Market is expected to grow significantly due to rise in adoption of drug discovery and development, personalized medicine and success of precision dozing. The successful outcome of research & development and critical FDA approvals enable the Bio-simulation Market to grow fast. Funding from government and private players are also key factors to drive the Global Bio-simulation Market. However, high cost of global Bio-simulation products and application are concern for the growth of the market.
North America generates highest revenues across the globe due to huge adoption of Bio-simulation technology and highest rate of healthcare spending followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Bio-simulation Market. Improved healthcare spending, infrastructure development and favourable government policies are the key factors which are expected to drive the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Market Segmentation, Geographical Analysis, Pipeline Analysis, Strategic Recommendations, Key Company Analysis, Key Findings, Market Insights, Analyst Insights and predictive analysis of the market.
The key players of Global Biosimulation Market includes Certara Us, Inc., Simulation Plus Inc.,Dassault Systèmes SA, Schrodinger Inc.,Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Entelos Holding Corporation, Genedata AG, Physiomics PLC, Rhenovia Pharma Ltd, Accelrys Inc., Leadscope, Insilico Biosciences, Compugen, Nimbus Healthcare, Insilico Biosciences Inc., Inhibox, Johnson & Johnson, Biovia, Leadinvent Technologies and so on. The key strategies adopted by the market players include R&D, partnership, FDA approval, product development, innovation and so on.
The Report covers:
Comprehensive research methodology of Global bio-simulation Market.
This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global bio-simulation Market.
Insights about market determinants which are stimulating the Global bio-simulation Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
5. CHEMICAL COMPUTING GROUP
7. DASSAULT SYSTÈMES
8. ENTELOS HOLDING CORPORATION
10. IN SILICO BIOSCIENCES INC.
12. JOHNSON & JOHNSON
15. NIMBUS HEALTHCARE
16. PHYSIOMICS RATIONAL THERAPEUTICS
17. RHENOVIA PHARMA
19. SIMULATION PLUS
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3466343-global-bio-simulation-market-research-and-forecast-2018-2023
Some Major Points from Table of content:
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1.1. GLOBAL RISE IN ADOPTION OF DRUG DISCOVERY AND DEVELOPMENT
3.1.2. GROWING ADOPTION OF PERSONALIZED MEDICINES
3.1.3. TECHNOLOGICAL ADVANCEMENT AND INNOVATION IN GLOBAL BIO-SIMULATION MARKET
3.1.4. COHESIVE GOVERNMENT POLICIES AND REGULATIONS
3.1.5. GLOBAL RISE IN HEALTHCARE EXPENDITURE
3.1.6. R&D TO DRIVE THE BIO-SIMULATION MARKET
3.2.1. HIGH COST OF BIO-SIMULATION IS A CONCERN FOR THE MARKET
3.2.2. CHANCES OF ERROR IN BIO-SIMULATION MODEL DEVELOPMENT APPROACHES
3.2.3. SOFTWARE FOR LARGE SCALE BIO-SIMULATIONS MAY CREATE PROBLEM AND COMPLEXITY
3.3.1. GLOBAL RISE IN PHARMACEUTICAL MARKET IS EXPECTED TO BOOST THE GLOBAL BIO-SIMULATION MARKET
3.3.2. R&D OUTCOMES OF DRUG DEVELOPMENT IN NEXT FEW YEARS ARE EXPECTED TO DRIVE THE GLOBAL BIO-SIMULATION MARKET
3.3.3. CLINICAL TRIALS ARE PREDICTED TO INCREASE IN NEXT FEW YEARS
3.3.4. REDUCTION IN LATE STAGE ATTRITION
4. MARKET SEGMENTATION
4.1. BIO-SIMULATION MARKET BY APPLICATION
4.1.1. DRUG DEVELOPMENT
184.108.40.206. GLOBAL PRECLINICAL TESTING
220.127.116.11. GLOBAL PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD)
18.104.22.168. GLOBAL CLINICAL TRIALS
4.1.2. DRUG DISCOVERY
22.214.171.124. TARGET IDENTIFICATION AND VALIDATION
126.96.36.199. LEAD IDENTIFICATION AND OPTIMIZATION
4.1.3. OTHER APPLICATIONS
4.2. BIO-SIMULATION MARKET BY PRODUCT
188.8.131.52. PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELLING AND SIMULATION SOFTWARE
184.108.40.206. MOLECULAR MODELLING AND SIMULATION SOFTWARE
220.127.116.11. PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING (PBPK) MODELLING AND SIMULATION SOFTWARE
18.104.22.168. TOXICITY PREDICTION SOFTWARE
22.214.171.124. TRIAL DESIGN SOFTWARE
126.96.36.199. OTHER SOFTWARE
4.2.3. EXTERNAL/CONTRACT SERVICES
4.3. BIO-SIMULATION MARKET BY END USERS
4.3.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
4.3.2. DRUG DISCOVERY AND DRUG DEVELOPMENT COMPANIES
4.3.3. EDUCATION CENTRES AND RESEARCH INSTITUTES
4.3.4. REGULATORY AUTHORITIES
For more information or any query mail at [email protected]
Name: Norah Trent
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Pune – 411028, Maharashtra, India